H-Guard Guards Hearts
The UK has made a £500 investment in Invizius' H-Guard—a product that aims to reduce the risk of heart disease by coating dialyzer fibers with an anti-inflamatory “primer” to make them more biocompatible.
Read the full article » | Posted 05-11-2018
Related Articles
- VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
- Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
- eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025